Atlas FDA

OIU

5 FDA 510(k) clearances · Product code

215 daysmedian time to decision
368 days90th percentile
5clearances measured

FDA profile

Official device name
Test, Epithelial Ovarian Tumor Associated Antigen (He4)
Device class
Class II (moderate risk)
Regulation
21 CFR 866.6010
Medical specialty
Immunology
Flags
Third-party review eligible
FDA definition
An enzyme immunometric assay for the quantitative determination of HE4 in human serum. The assay is to be used as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer. Serial testing for patient HE4 assay values should be used in conjunction with other clinical methods used for monitoring ovarian cancer. It is not intended to estimate or assess the risk of disease outcomes of patients.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
Lumipulse G HE4 Immunoreaction Cartridges, Lumipulse G HE4 Calibrators (K151378)Fujirebio Diagnostics,Inc.2015-11-24
ELECSYS HE4, ELECSYS HE4 CALSET, ELECSYS PRECICONTROL HE4, ELECSYS HE4 CALCHECK 5 (K112624)Roche Diagnostics2012-09-10
FUJIREBIO DIAGNOSTICS TUMOR MARKER CONTROL (K103676)Fujirebio Diagnostics,Inc.2011-07-19
ARCHITECT HE4, ARCHITECT HE4 CALIBRATORS AND ARCHITECT HE4 CONTROLS, MODELS 2, 2P54, 2P54-01, 2P54-10 SP54-01, (K093957)Fujirebio Diagnostics,Inc.2010-03-18
HE4 EIA, MODEL: 404-10 US (K072939)Fujirebio Diagnostics,Inc.2008-06-09

Track OIU automatically

Every clearance here is in the API, with alerts when new ones post.